全文获取类型
收费全文 | 15473篇 |
免费 | 1422篇 |
国内免费 | 1056篇 |
专业分类
耳鼻咽喉 | 102篇 |
儿科学 | 117篇 |
妇产科学 | 376篇 |
基础医学 | 1763篇 |
口腔科学 | 914篇 |
临床医学 | 1627篇 |
内科学 | 2389篇 |
皮肤病学 | 163篇 |
神经病学 | 1002篇 |
特种医学 | 606篇 |
外国民族医学 | 3篇 |
外科学 | 1874篇 |
综合类 | 1607篇 |
现状与发展 | 4篇 |
预防医学 | 1504篇 |
眼科学 | 143篇 |
药学 | 1803篇 |
8篇 | |
中国医学 | 465篇 |
肿瘤学 | 1481篇 |
出版年
2024年 | 79篇 |
2023年 | 968篇 |
2022年 | 1190篇 |
2021年 | 1292篇 |
2020年 | 1270篇 |
2019年 | 716篇 |
2018年 | 617篇 |
2017年 | 738篇 |
2016年 | 786篇 |
2015年 | 766篇 |
2014年 | 1558篇 |
2013年 | 1037篇 |
2012年 | 1211篇 |
2011年 | 1102篇 |
2010年 | 889篇 |
2009年 | 754篇 |
2008年 | 414篇 |
2007年 | 549篇 |
2006年 | 352篇 |
2005年 | 227篇 |
2004年 | 142篇 |
2003年 | 110篇 |
2002年 | 117篇 |
2001年 | 105篇 |
2000年 | 78篇 |
1999年 | 93篇 |
1998年 | 101篇 |
1997年 | 66篇 |
1996年 | 94篇 |
1995年 | 82篇 |
1994年 | 54篇 |
1993年 | 36篇 |
1992年 | 22篇 |
1991年 | 26篇 |
1990年 | 28篇 |
1989年 | 20篇 |
1988年 | 51篇 |
1987年 | 43篇 |
1986年 | 41篇 |
1985年 | 13篇 |
1984年 | 26篇 |
1983年 | 17篇 |
1982年 | 17篇 |
1981年 | 22篇 |
1980年 | 17篇 |
1979年 | 1篇 |
1978年 | 4篇 |
1977年 | 6篇 |
1976年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
Human heat shock protein 60 (Hsp60), is an endogenous β-cells autoantigen, it could postpone the onset of insulitis and sooner type 1 diabetes mellitus. P277 is one of Hsp65 determinants at position 437–469 of amino acids cascaded. Meanwhile, it's already well-known that there were several better anti-diabetic B epitopes, such as insulinoma antigen-2 (IA-2). Currently, fusion protein IA2P2 has constructed in order to enhance its pharmacological efficacy. In addition, added homologous bacterial-derived Hsp65 and His tag were beneficial to protein immunogenicity and purification separately. So, finally we examined a fusion protein His-Hsp65-6IA2P2 could regulate Th2 immune response and reduce natural diabetic incidence in NOD mice. We constructed two express vector pET28a–His-Hsp65-6P277 and pET28a–His-Hsp65-6IA2P2. After purification, we observed that triple intranasal administration of these two fusion protein in 4-week-old NOD mice maintained normal blood glucose and weight, with a lower diabetic or insulitis incidence. Consistent with induced splenic T cells proliferation and tolerance, His-Hsp65-6IA2P2-treated mice performed reduced IFN-γ and increased IL-10 level. In conclusion, we suggested that fusion protein His-Hsp65-6IA2P2 could be reconstructed and purified successively. Furthermore, nasal administration of this fusion protein could rebalance T cells population and prevent T1DM. 相似文献
2.
3.
Although numerous studies have proven the medicinal values of Yulangsan polysaccharide (YLSP), the toxicity of this active ingredient is unknown. In the acute toxicity study, a single oral administration of 24 g/kg YLSP caused neither toxicological symptoms nor mortality, and the LD50 was estimated >24 g/kg. In the chronic toxicity study, we administered doses of 0, 0.6, 1.2 and 2.4 g/kg YLSP in rats by oral gavage for 26 weeks followed by a 3-week recovery period. There was no mortality or remarkable clinical signs observed during this 26-week study. Additionally, there were no toxic differences in the following parameters: body weight, food consumption, hematology, clinical biochemistry, organ weight, and macroscopic findings. There were no adverse effects on histopathology observed in males or female rats treated with YLSP. Based on the results, the no-observed-adverse-effect-level of YLSP in rats is greater than 2.4 g/kg when administered orally for 26 consecutive weeks. 相似文献
4.
5.
6.
《Vaccine》2020,38(39):6141-6152
Influenza vaccination is considered the most valuable means to prevent and control seasonal influenza infections, which causes various clinical symptoms, ranging from mild cough and fever to even death. Among various influenza vaccine types, the inactivated subunit type is known to provide improved safety with reduced reactogenicity. However, there are some drawbacks associated with inactivated subunit type vaccines, with the main ones being its low immunogenicity and the induction of Th2-biased immune responses. In this study, we investigated the role of a single-stranded RNA (ssRNA) derived from the intergenic region in the internal ribosome entry site of the Cricket paralysis virus as an adjuvant rather than the universal vaccine for a seasonal inactivated subunit influenza vaccine. The ssRNA adjuvant stimulated not only well-balanced cellular (indicated by IgG2a, IFN-γ, IL-2, and TNF-α) and humoral (indicated by IgG1 and IL-4) immune responses but also a mucosal immune response (indicated by IgA), a key protector against respiratory virus infections. It also increases the HI titer, the surrogate marker of influenza vaccine efficacy. Furthermore, ssRNA adjuvant confers cross-protective immune responses against heterologous influenza virus infection while promoting enhanced viral clearance. Moreover, ssRNA adjuvant increases the number of memory CD4+ and CD8+ T cells, which can be expected to induce long-term immune responses. Therefore, this ssRNA-adjuvanted seasonal inactivated subunit influenza vaccine might be the best influenza vaccine generating robust humoral and cellular immune responses and conferring cross-protective and long-term immunity. 相似文献
7.
8.
9.
10.